FDA Inspection 1230061 — Qualgen, LLC

Qualgen, LLC — FEI 3011286349

The FDA completed an inspection of Qualgen, LLC on March 19, 2024 in Edmond, OK. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 14 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 19, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Edmond, OK (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
111121 CFR 211.25(a)Training , Education , Experience overall
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
136121 CFR 211.100(a)Absence of Written Procedures
145121 CFR 211.113(b)Procedures for sterile drug products
145221 CFR 211.113(b)Validation lacking for sterile drug products
155021 CFR 211.125(f)Procedures Written and Followed
202021 CFR 211.188(b)(8)Labeling Control Records and Label Copies
202721 CFR 211.192Investigations of discrepancies, failures
356121 CFR 211.56(b)Written sanitation procedures lacking
356521 CFR 211.58Buildings not maintained in good state of repair
438921 CFR 211.198(a)Procedures to be written and followed
440021 CFR 211.186(b)(8)Description of containers, labels, et. al.